MedTrace Logo

Influence of HRS9531 on Pharmacokinetics of Metformin in Healthy Subjects

NCT06654960 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-01-07

No results posted yet for this study

Summary

The purpose of this study is to evaluate the influence of HRS9531 injection on pharmacokinetics of metformin in healthy subjects.

Conditions

Interventions

DRUG

HRS9531 injection

HRS9531 injection single dose.

DRUG

Metformin Hydrochloride tablets

Metformin Hydrochloride tablets 500mg.

Sponsors & Collaborators

  • Fujian Shengdi Pharmaceutical Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-05
Primary Completion
2024-12-26
Completion
2024-12-26

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06654960 on ClinicalTrials.gov